Cannabinoids in hyperhidrosis.


Journal

The Journal of dermatological treatment
ISSN: 1471-1753
Titre abrégé: J Dermatolog Treat
Pays: England
ID NLM: 8918133

Informations de publication

Date de publication:
Dec 2023
Historique:
pubmed: 7 10 2022
medline: 25 2 2023
entrez: 6 10 2022
Statut: ppublish

Résumé

Hyperhidrosis can significantly curtail patient quality of life, from debilitating physical symptoms to social stigmatization and reduced life opportunities. Current treatments often prove unsatisfactory, especially in sufferers of generalized hyperhidrosis. In this open trial, we present the case of a refractory generalized hyperhidrosis treated with cannabinoids. We found a remarkable reduction in the volume of sweat and an improvement to the patient's quality of life using this novel low-cost and low-impact approach.

Identifiants

pubmed: 36200741
doi: 10.1080/09546634.2022.2127308
doi:

Substances chimiques

Cannabinoids 0

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2127308

Auteurs

Till Kaemmerer (T)

Department of Dermatology and Allergy, University Hospital, LMU Munich, Munich, Germany.

Benjamin Maximilian Clanner-Engelshofen (BM)

Department of Dermatology and Allergy, University Hospital, LMU Munich, Munich, Germany.

Tony Lesmeister (T)

Department of Dermatology and Allergy, University Hospital, LMU Munich, Munich, Germany.

Lars Einar French (LE)

Department of Dermatology and Allergy, University Hospital, LMU Munich, Munich, Germany.
Dr. Phillip Frost Department of Dermatology & Cutaneous Surgery, Miller School of Medicine, University of Miami, Miami, FL, USA.
Department of Oral, Maxillofacial and Facial Plastic Surgery, University Medical Centre Mainz, Mainz, Germany.

Markus Reinholz (M)

Department of Dermatology and Allergy, University Hospital, LMU Munich, Munich, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH